ExoticRx · exoticrx.com/drugs/hydroxyurea
Hydrea, Droxia
Inhibits ribonucleotide reductase, blocking conversion of ribonucleotides to deoxyribonucleotides. S-phase specific. Reduces elevated cell counts rapidly.
Myelosuppression is dose-dependent and predictable. Monitor CBC weekly initially. Megaloblastic changes expected. Used for polycythemia vera, CML, and meningioma in dogs and cats.
Each ExoticRx dose rule is graded by the strength of its primary evidence — see the editorial process.
Free-tier preview — dog and cat dosing. Pro and Student unlock all 2 species including reptiles, birds, pocket pets, livestock, and equine.
| Species | Route | Dose | Frequency | Evidence | Source |
|---|---|---|---|---|---|
| Dog (Domestic) | PO | 50–80 mg/kg | 50mg/kg PO q24h (some protocols q48h) | Moderate | Withrow & MacEwen's Small Animal Clinical Oncology, 6th Ed |
| Cat (Domestic) | PO | 25–50 mg/kg | 25mg/kg PO q48-72h | Moderate | Withrow & MacEwen's Small Animal Clinical Oncology, 6th Ed |
Upgrade to Pro or Student to access full drug details including mechanism of action, warnings, dose ranges, and frequency.
View PlansSource citations and evidence levels available on the live page. Reference only — verify against current literature before clinical use.